跳至主要内容
临床试验/ISRCTN96078487
ISRCTN96078487已完成不适用

Medical Management of Severe Aortic Regurgitation in Asymptomatic Patients with Normal Left Ventricular Function with Valsartan - A Study to Assess Disease Progressio

Record Provided by the NHSTCT Register - 2006 Update - Department of Health0 个研究点目标入组 0 人开始时间: 2006年9月29日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects are to be recruited from patients either under active follow-up or active referral as in-patients or out-patients to the Department of Cardiology, University Hospital Birmingham.
  • 1. Asymptomatic or mildly symptomatic patients with moderate - severe AR (NYHA II or less; CSA <2)
  • 2. Normal LVEF >50%
  • 3. Preserved LV dimensions (LVIDs <5.5cm)

排除标准

  • 1. Acute, severe AR or rapid deterioration of AR (within the preceding six months)
  • 2. Mixed aortic stenosis and regurgitation (valve stenosis > mild defined as peak gradient above 20 mm Hg)
  • 3. Evidence of additional valvular or congenital heart disease on echocardiographic study sufficient to require surgical intervention
  • 4. Abnormal left ventricular ejection fraction (<50 percent)
  • 5. Contra-indications to Angiotensin II receptor antagonist therapy (previous intolerance; known or suspected renovascular hypertension; creatinine >150 umol/L, serum potassium > 5.9 mmol/l) or to treatment with nifedipine
  • 6. Contra-indication to cardiac MRI

研究者

发起方
Record Provided by the NHSTCT Register - 2006 Update - Department of Health

相似试验